Concepedia

Tolerability of Concurrent Chemoradiation Therapy With Gemcitabine (GemX), With and Without Prior Neoadjuvant Chemotherapy, in Muscle Invasive Bladder Cancer

Catherine Thompson, Nuradh Joseph, Benjamin M. Sanderson, John Logue, James Wylie, Tony Elliott, J. Lyons, Carmel Anandadas, Ananya Choudhury

International Journal of Radiation Oncology*Biology*Physics · 2016 · 32 citations · 22 references

DOIFull text

Open access

Concepts

References

22

Radiotherapy with or without Chemotherapy in Muscle-Invasive Bladder Cancer

Nicholas D. James, Syed A. Hussain, Emma Hall et al. · New England Journal of Medicine · 2012 · 950 citations · Full text

, , +9

International Phase III Trial Assessing Neoadjuvant Cisplatin, Methotrexate, and Vinblastine Chemotherapy for Muscle-Invasive Bladder Cancer: Long-Term Results of the BA06 30894 Trial

Journal of Clinical Oncology · 2011 · 947 citations · Full text

, , +8

Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group.

C Coppin, Mary Gospodarowicz, K W James et al. · Journal of Clinical Oncology · 1996 · 472 citations

, , +15

Long-Term Outcomes in Patients With Muscle-Invasive Bladder Cancer After Selective Bladder-Preserving Combined-Modality Therapy: A Pooled Analysis of Radiation Therapy Oncology Group Protocols 8802, 8903, 9506, 9706, 9906, and 0233

Raymond H. Mak, Daniel Hunt, William U. Shipley et al. · Journal of Clinical Oncology · 2014 · 452 citations · Full text

, , +14

Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH Experience

Jason A. Efstathiou, Daphna Y. Spiegel, William U. Shipley et al. · European Urology · 2011 · 427 citations

, , +13